TGTX
TG Therapeutics Inc
Price:  
16.77 
USD
Volume:  
1,534,234.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX EV/EBITDA

-50.8%
Upside

As of 2024-06-20, the EV/EBITDA ratio of TG Therapeutics Inc (TGTX) is 48.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TGTX's latest enterprise value is 2,617.48 mil USD. TGTX's TTM EBITDA according to its financial statements is 53.89 mil USD. Dividing these 2 quantities gives us the above TGTX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 17.7x - 25.9x 22.2x
Forward P/E multiples 21.8x - 25.6x 23.4x
Fair Price 6.02 - 9.80 8.25
Upside -64.1% - -41.6% -50.8%
16.77 USD
Stock Price
8.25 USD
Fair Price

TGTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-18 48.58
2024-06-17 48.00
2024-06-14 47.94
2024-06-13 48.55
2024-06-12 48.69
2024-06-11 46.80
2024-06-10 46.08
2024-06-07 45.94
2024-06-06 45.82
2024-06-05 47.89
2024-06-04 46.97
2024-06-03 47.31
2024-05-31 47.23
2024-05-30 48.92
2024-05-29 47.40
2024-05-28 48.80
2024-05-24 48.40
2024-05-23 49.18
2024-05-22 51.24
2024-05-21 48.09
2024-05-20 47.74
2024-05-17 47.74
2024-05-16 50.44
2024-05-15 51.30
2024-05-14 51.99
2024-05-13 50.15
2024-05-10 48.15
2024-05-09 49.01
2024-05-08 49.58
2024-05-07 49.75
2024-05-06 47.83
2024-05-03 46.91
2024-05-02 47.57
2024-05-01 46.02
2024-04-30 39.66
2024-04-29 38.68
2024-04-26 39.11
2024-04-25 40.37
2024-04-24 40.57
2024-04-23 41.35
2024-04-22 40.92
2024-04-19 40.00
2024-04-18 40.60
2024-04-17 40.11
2024-04-16 40.63
2024-04-15 40.83
2024-04-12 41.09
2024-04-11 42.81
2024-04-10 42.67
2024-04-09 43.79